DOPATREE
Preview
Open in TheBrain
DOPATREE
UNITED STATES GOVERNMENT ORGANIZATIONS / LISTINGS
US FOOD AND DRUG ADMINISTRATION (FDA)
DRUGS AND BIOLOGICS / RELATED / US
DRUG SAFETY AND BIOLOGIC SAFETY (PHARMACOVIGILANCE, PV, CLINICAL, POSTMARKETING, SERIOUS ADVERSE EVENT, SAE, IND, 7-DAY, 15-DAY, EXPEDITED, SIDE EFFECTS, ICSR, PSUR, LITERATURE, SURVEILLANCE, E2B, SAFETY REPORTING, DATA, MEDICATION)
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / INTL
TREATMENT-RELATED CONDITIONS-ALL (DRUG-RELATED, BIOLOGIC-RELATED, DEVICE-RELATED, TREATMENT EMERGENT ADVERSE EVENTS, TEAE, ADVERSE DRUG REACTIONS, SIDE EFFECTS, ALL TOXICITIES, TOXICITY, PRODUCT-RELATED, DRUG-INDUCED)
TREATMENT-RELATED CONDITIONS / LISTINGS
HEPATOTOXICITY (DRUG-INDUCED LIVER INJURY, DILI, HEPATIC TOXICITY, LIVER TOXICITY, DRUG INDUCED)
HEPATOTOXICITY / MITIGATIONS
Parents
HEPATOTOXICITY (DRUG-INDUCED LIVER INJURY, DILI, HEPATIC TOXICITY, LIVER TOXICITY, DRUG INDUCED)
Children
INTERRUPT, REDUCE, OR DISCONTINUE TREATMENT DOSE OR RATE DEPENDING ON SEVERITY
MONITOR LIVER ENZYMES AT BASELINE AND DURING TREATMENT